Atlas Trials

M8891 First in Human in Solid Tumors

Clinical trial NCT03138538 · TERMINATED

Trial details

NCT number
NCT03138538
Sponsor
EMD Serono Research & Development Institute, Inc.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid TumorsMetastatic Renal Cell Carcinoma
Start date
2017-08-08
Primary completion
2020-09-16
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.